ECHO Study Finds No Association Between Arsenic Exposure and Birth Outcomes

Authors: Jonathan Lewis, Emily A. Knapp, Amii M. Kress, et al.

Who sponsored this study?

The Environmental influences on Child Health Outcomes (ECHO) Program, Office of The Director, National Institutes of Health supported this research.

Why was this study needed?

Arsenic is a naturally occurring, toxic chemical that can be present in groundwater and surface water. Drinking water, as a result, is one of the most common ways people are exposed to arsenic in the U.S. and globally. There have been a limited number of small studies of the association between arsenic and birth outcomes, mostly outside of the U.S. In this study, ECHO researchers examined a diverse group of pregnant participants from across the country to determine if birth outcomes—birth weight, gestational age at birth, preterm birth, and size at birth—are influenced by arsenic concentrations that are above regulatory action levels.

What were the study results?

Researchers found that low birth weight, gestational age at birth, preterm birth, and birth size were not associated with potential exposure to arsenic among pregnant women living in a county with active arsenic level violations. There was a statistically significant increase in birth weight among infants whose mother’s experienced continuous exposure (from three months before conception through birth) compared with infants from areas without violations.

Footnote: Results reported here are for a single study. Other or future studies may provide new information or different results. You should always consult with a qualified healthcare provider for diagnosis and for answers to your personal questions.

What was this study's impact?

Overall, drinking water violations for arsenic that could indicate the presence of the chemical above regulatory action levels are relatively uncommon. Researchers captured proxy exposure using residential history arsenic violations from the preconception period throughout pregnancy, a time when environmental influences could disrupt fetal growth.

Who was involved?

The study included over 15,000 mother-child pairs at 51 ECHO Cohort Study Sites across the United States. The children were born in 2006 or later, as the U.S. Environmental Protection Agency (EPA) changed the enforceable standard for arsenic concentrations in drinking water to 10 parts per billion during that year. Only 794 participants experienced arsenic violations.

What happened during the study?

Researchers grouped pregnant participants based on where they lived three months before conception and during pregnancy. Within those areas, investigators determined which public water systems had violations for arsenic. Then they looked at how living in a county with an arsenic violation might affect birth outcomes.

What happens next?

Future research could better identify ECHO participants’ exposure to arsenic by considering other sources of drinking water (e.g., bottled or filtered water) and exposure to arsenic in foods.

Where can I learn more?

Access the full journal article, titled “Associations Between Area-Level Arsenic Exposure and Adverse Birth Outcomes: An ECHO-Wide Cohort Analysis,” in Environmental Research.

The content is the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Published November 1, 2023

Access the associated article.

Download this summary

ECHO Study Finds No Association Between Arsenic Exposure and Birth Outcomes

ECHO Research Identifies Variety of Low-calorie, Nutrient-rich Foods for Optimal Prenatal Nutrition

<< Back to Research Summaries

ECHO Research Identifies Variety of Low-calorie, Nutrient-rich Foods for Optimal Prenatal Nutrition

Authors: Katherine Sauder, Catherine Cohen, et al.

Who sponsored this study?

The Environmental influences on Child Health Outcomes (ECHO) Program, Office of The Director, National Institutes of Health supported this research.

Why was the study needed?

Most pregnant women in the U.S. are at risk of not getting enough of nutrients like vitamin A, vitamin D, folate, calcium, iron, and omega-3 fatty acids from foods alone. Previous ECHO Cohort research found that only one prenatal supplement available in the U.S. may give pregnant women the optimal amounts of each of these six nutrients. However, that supplement costs $200 per month and requires the patient to take seven pills a day. Researchers in this study turned to diet to explore energy-efficient foods that could provide the right amounts of these nutrients for pregnant patients.

What were the study results?

Researchers in this study identified more than 2,300 low-calorie foods with enough of at least one of the six nutrients important in pregnancy, including many with reasonable serving amounts to avoid excessive intake. For instance, consuming an additional 0.2 cups of raw carrots could provide the optimal amount of vitamin A. An additional 2.6 cups of reduced-fat milk could provide the optimal amount of vitamin D. An additional 0.4 cups of edamame could provide the optimal amount of folic acid. An additional 1 cup of a nutritional drink or shake could provide the optimal amount of calcium. An additional 0.9 cups of multigrain cereal could provide the optimal amount of iron. An additional 0.1 cups of canned chicken could provide the optimal amount of omega-3 fatty acids.

However, no single food evaluated gave enough of all six nutrients. Seaweed (raw or cooked without fat) provided sufficient vitamin A, folate, calcium, iron, and omega-3s but would require consumption of more than 5 cups per day. Twenty-one other foods and beverages (mainly fish, vegetables, and beverages) provided target amounts of four of the six key nutrients. Few foods met targets for vitamin D or iron, suggesting that dietary supplements may be necessary to meet those nutrient needs. Other foods could be added in limited amounts to help meet intake targets without exceeding caloric recommendations or nutrient safety limits.

Footnote: Results reported here are for a single study. Other or future studies may provide new information or different results. You should always consult with a qualified healthcare provider for diagnosis and for answers to your personal questions.

What was the study's impact?

Results highlight the difficulty in meeting nutritional requirements from diet alone and can inform pregnant women and their doctors about dietary changes and additional supplements that can improve nutrition during pregnancy. Pregnant women can focus on boosting prenatal intake of low-mercury fish, low-fat dairy, green and leafy vegetables, and fortified cereals to meet nutrient recommendations.

Who was involved?

This study included 2,450 pregnant participants from six ECHO Cohort Study Sites located across the U.S.

What happened during the study?

The researchers compared over 2,300 foods and beverages consumed in the U.S., focusing on the nutrients that are most important for maternal and infant health: vitamin A, vitamin D, folic acid, calcium, iron, and omega-3 fatty acids. ECHO researchers looked at foods and drinks that pregnant participants consumed during their pregnancies and then calculated how much of these six nutrients they were getting from their diet. The researchers compared the participants’ diets to nutrition recommendations for pregnancy to determine the amount of nutrients the participants would need from foods to make up for the gaps in their diet.

What happens next?

Future research may focus on studying exactly how much of these nutrients are needed for pregnant women.

Where can I learn more?

Access the full journal article, titled “Identifying Foods that Optimize Intake of Key Micronutrients During Pregnancy" in The Journal of Nutrition.

The content is the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Published September 27, 2023

Access the associated article.

Download this summary

ECHO Research Identifies Variety of Low-calorie, Nutrient-rich Foods for Optimal Prenatal Nutrition

ECHO Cohort Researchers Find Association Between Some Prenatal Chemical Exposures and Postpartum Depression

<< Back to Research Summaries

ECHO Cohort Researchers Find Association Between Some Prenatal Chemical Exposures and Postpartum Depression

Authors: Melanie Jacobson, et al.

Who sponsored this study?

The Environmental influences on Child Health Outcomes (ECHO) Program, Office of the Director, National Institutes of Health supported this research.

Why was this study needed?

Postpartum depression affects up to 20% of new mothers, making it the most common pregnancy complication to occur after delivery. Postpartum depression can impact a mother’s daily functioning, quality of life, and long-term health. Furthermore, it is associated with poor mother-child attachment, which can impact child health and development.

Factors like genetics and stress can make some people more likely to experience postpartum depression, but researchers are still trying to understand how synthetic chemicals might also play a role. Chemicals such as phenols, phthalates, and parabens can be found in plastics and personal care products. While these chemicals are nonpersistent, meaning that they don’t linger in the environment, their presence is widespread due to frequent exposure through diet, absorption through skin, and inhalation. The investigators in this study wanted to examine the extent to which exposure to these chemicals might be associated with postpartum depression symptoms.

What were the study results?

Prenatal phthalate concentrations were associated with increased odds of slightly higher postpartum depression scores, and the condition was observed to be more likely in people who were Hispanic, had lower education levels, and had prenatal depression.

Footnote: Results reported here are for a single study. Other or future studies may provide new information or different results. You should not make changes to your health without first consulting your healthcare professional.

What was the study's impact?

Of the many synthetic chemicals investigated, only prenatal phthalate concentrations were associated with increased odds of postpartum depression. This suggests that finding ways to reduce prenatal exposure to phthalates might reduce the frequency of postpartum depression.

Who was involved?

Researchers used data from 2,174 pregnant individuals across five study sites. This information included data on urinary chemical concentrations from at least one point during the pregnancy and a self-reported postnatal depression assessment between two weeks and 12 months after delivery.

What happened during the study?

Researchers measured the concentrations of nonpersistent chemicals in urine samples. Researchers also collected, between two weeks and 12 months after delivery, data using self-reported postnatal depression assessments completed by the same individuals. Screening instruments indicated the presence or absence of postnatal depressive symptoms. Data was then harmonized to the Patient-Reported Measurement Information System (PROMIS) Depression scale.

What happens next?

While this is believed to be the largest study to-date examining the effects of environmental chemicals on postpartum depression, future studies are needed to replicate this research with larger sample sizes in diverse populations.

Where can I learn more?

Access the full journal article, titled “Prenatal exposure to nonpersistent environmental chemicals and postpartum depression,” in JAMA Psychiatry.

The content is the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Published September 20, 2023

Access the associated article.

Download this summary

ECHO Cohort Researchers Find Association Between Some Prenatal Chemical Exposures and Postpartum Depression.

ECHO Researchers Develop a National Exposure Index for Combined Environmental Hazards and Social Stressors

<< Back to Research Summaries

ECHO Researchers Develop a National Exposure Index for Combined Environmental Hazards and Social Stressors

Authors: Sheena Martenies, et al.

Who sponsored this study?

The Environmental influences on Child Health Outcomes (ECHO) Program, Office of the Director, National Institutes of Health supported this research.

Why was this study needed?

There is growing interest in understanding the combined effect of environmental hazards and social stressors on the health and development of children. While there are a number of tools for assessing the impact of environmental and social stressors, these tools can be limiting in the number of indicators they measure, the geographical area they cover, or the period of time they include for their observations. In this study, researchers developed a combined exposure index with national coverage that compiled available data on several environmental and social indicators during prenatal and early-life periods. This index is now being used to facilitate ECHO-wide analyses that consider multiple neighborhood-level exposures at the same time.

What were the study results?

The combined exposure index, which summarized exposures to multiple environmental hazards and social stressors at the neighborhood level, differed by region. The level of combined exposures were highest in the western and northeastern regions of the United States. Researchers also found that pregnant participants who identified as Black and Hispanic had higher exposures compared to White and non-Hispanic participants. Exposure values were also higher for pregnant participants with lower educational attainment.

Footnote: Results reported here are for a single study. Other or future studies may provide new information or different results. You should not make changes to your health without first consulting your healthcare professional.

What was the study's impact?

The study analyzed how the combined exposure to several environmental hazards and social stressors during pregnancy may impact health. Researchers found that pregnant participants from minority groups were more likely to have higher exposures to these hazards. These results support findings from similar studies that suggest that neighborhood quality might influence maternal and child health outcomes, and may contribute to health disparities.

Who was involved?

This study included data from 14,072 pregnancies from 46 different ECHO research sites across the United States.

What happened during the study?

Researchers developed a combined exposure index using publicly available data on environmental hazards and social stressors. The data included variables such as air pollution, features of the built environment, and neighborhood socioeconomic status, and then estimated the likelihood of exposure to these variables for participants in the study, based on where they lived.

What happens next?

Researchers can use this exposure index in future studies to look at how neighborhood features influence child health outcomes. Future studies would benefit from national datasets for key environmental health concerns, such as water contaminants and pesticides, and social stressors that may disproportionally affect certain groups.

Where can I learn more?

Access the full journal article, titled “Developing a National-Scale Exposure Index for Combined Environmental Hazards and Social Stressors and Applications to the Environmental Influences on Child Health Outcomes (ECHO) Cohort,” in the International Journal of Environmental Research and Public Health.

The content is the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Published July 10, 2023

Access the associated article.

Download this summary

ECHO Researchers Develop a National Exposure Index for Combined Environmental Hazards and Social Stressors

“Eat, Sleep, Console” approach shown to be more effective in caring for newborns with neonatal opioid withdrawal syndrome

<< Back to Research Summaries

“Eat, Sleep, Console” approach shown to be more effective in caring for newborns with neonatal opioid withdrawal syndrome

Author(s): Leslie Young, Lori Devlin, Stephanie Merhar, et al.

Who sponsored this study?

This clinical trial is a collaboration between the National Institutes of Health (NIH) Environmental influences on Child Health Outcomes (ECHO) Program and the NIH’s Eunice Kennedy Shriver Institute of Child Health and Human Development (NICHD), funded through the NIH Helping to End Addiction Long-term® Initiative (HEAL).

What were the study results?

Researchers found that the “Eat, Sleep, Console” (ESC) care approach is more effective for the treatment of infants with neonatal opioid withdrawal syndrome (NOWS) than usual approaches to care. ESC focuses on care without the use of medications, and includes holding, swaddling, and rocking the baby in a quiet, calm environment.

In this clinical trial, infants cared for with ESC were medically ready for discharge after an average of 8.2 days, whereas infants cared for with usual approaches were medically ready for discharge after 14.9 days. That means that babies were, on average, able to go home 6.7 days sooner. Newborns cared for with ESC were also 63% less likely to receive medication as part of their treatment (19.5% in the ESC group received opioid therapy, compared to 52% in the Finnegan Neonatal Abstinence Scoring Tool [FNAST] group). Safety outcomes at three months of age were similar between both groups.

What was the study's impact?

Newborns exposed to opioids before birth may develop symptoms of NOWS. These symptoms may include tremors, excessive crying and irritability, and problems with sleeping and feeding. In the United States, at least one newborn is diagnosed with NOWS every 24 minutes. There has not previously been strong evidence to support a standard approach to the care of babies with NOWS, and medical care for these babies has varied widely across hospitals.

This study gives hospitals an evidence-based approach to care for babies with NOWS. Compared with usual care using traditional scoring approaches, the ESC care approach substantially shortens the time infants spend in the hospital. The ESC approach has also been shown as safe as usual care approaches after discharge through early infancy.

Why was this study needed?

Hospitals have different approaches for caring for these babies. They often use FNAST to assess newborns with NOWS. The FNAST is an extensive scoring system that assesses signs of withdrawal in more than 20 areas. Concerns have been raised about its subjectivity and overestimation of the need for opioid medication.

The ESC care approach was developed about eight years ago and is growing in popularity in some nurseries, but this method had not previously been rigorously tested. ESC assessments are centered on an infant’s ability to eat, sleep and be consoled without the introduction of medications, and this approach keeps mother and baby together, empowering families to play a larger role in the care of their infants. However, the widespread adoption of ESC without solid evidence of its effectiveness and safety has raised concerns about potentially undertreating infants or discharging them too early. This study tested the extent to which ESC might be a better way to care for babies with NOWS.

Who was involved?

The study examined the hospital outcomes of a diverse group of 1,305 opioid-exposed infants from 26 hospitals across the U.S. The study is part of the Advancing Clinical Trials in Neonatal Opioid Withdrawal (ACT NOW) Collaborative, which brings together two existing pediatric research networks: the NICHD Neonatal Research Network and the ECHO Program’s Institutional Development Award (IDeA) States Pediatric Clinical Trials Network (ISPCTN).

What happened during the study?

The researchers randomized 26 hospitals to transition from FNAST-based care to the ESC care approach at different times. They then evaluated each method based on how soon infants were ready to leave the hospital and whether infants were treated with opioid medication to manage their symptoms.

Footnote: Results reported here are for a single study. Other or future studies may provide new information or different results. You should not make changes to your healthcare without first consulting your healthcare professional.

What happens next?

The researchers will continue to follow up with a subset of the participating infants for two more years to see if the ESC approach has any effect on infant and family well-being.

Where can I learn more?

Access the full journal article, titled “Eat, sleep, console approach versus usual care for neonatal opioid withdrawal,” in the New England Journal of Medicine.

Learn more about this clinical trial and the NIH Helping to End Addiction Long-term^® Initiative on the NIH HEAL Initiative^® website.

The content is the responsibility of the authors and does not necessarily represent the official views of the NIH.

Access the associated article.

Published: April 30, 2023

Download this summary

“Eat, Sleep, Console” approach shown to be more effective in caring for newborns with neonatal opioid withdrawal syndrome

Read Related Research Summaries

How does prenatal opioid exposure affect child outcomes?

Author(s): Elisabeth Conradt, Sheila Crowell and Barry Lester

Understanding characteristics associated with opioid use during pregnancy

Authors: Ruby H.N. Nguyen, Monica McGrath, et al.

Phenobarbital and Clonidine as Secondary Medications for Neonatal Opioid Withdrawal Syndrome

Author(s): Stephanie Merhar, Songthip Ounpraseuth, Lori Devlin, et al.

Site-Level Variation in the Characteristics and Care of Infants with Neonatal Opioid Withdrawal

Author(s): Leslie Young, Zhuopei Hu, Robert Annett, et al.

The ACT NOW Clinical Practice Survey: Gaps in the Care of Infants With Neonatal Opioid Withdrawal Syndrome

Author(s): Jessica Snowden, Akshatha, Robert Annett, et al.

ECHO Study Suggests Most Prenatal Vitamins May Not Provide All of the Nutrients Pregnant Women Need

<< Back to Research Summaries

ECHO Study Suggests Most Prenatal Vitamins May Not Provide All of the Nutrients Pregnant Women Need

Authors: Katherine Sauder, et al.

Who sponsored this study?

This research was supported by the Environmental influences on Child Health Outcomes (ECHO) Program, Office of The Director, National Institutes of Health.

What were the study results?

Out of all the prenatal supplements analyzed, the study found one that may potentially give pregnant patients the optimal amounts of the most important nutrients. But, the monthly cost of this supplement can be too high for some people, and it requires pregnant women to take seven pills a day. To ensure that pregnant women have accessible options for prenatal vitamins, the researchers looked for dietary supplements containing close to the needed amounts of nutrients that cost less and required only one to two pills a day.

See the full publication (Appendix A) for a list of the prenatal supplements analyzed during this study and their nutritional contents.

Footnote: Results reported here are for a single study. Other or future studies may provide new information or different results. You should not make changes to your health without first consulting your healthcare professional.

What was the study's impact?

This study can inform pregnant women and their doctors about key nutrients they may be missing in their diet and what prenatal vitamins they can take to get those nutrients. Companies that manufacture prenatal vitamins can also use the results of this study to understand how much of these nutrients should be in the products they make. Importantly, this study highlights the ongoing need for more prenatal vitamin options that are low cost and convenient, while still containing the optimal amounts of key nutrients.

Why was the study needed?

It is important that pregnant women get the right amounts of the nutrients they need for a healthy pregnancy. There are thousands of options for prenatal dietary supplements in the United States, so ECHO researchers conducted this study to help pregnant women and doctors pick the ones that contain optimal doses of key micronutrients to support a healthy pregnancy.

Who was involved?

This study included 2,450 pregnant participants from six ECHO cohorts located across the United States.

What happened during the study?

ECHO researchers first analyzed data about what the participants ate and drank during their pregnancies. Then, they calculated how much vitamin A, vitamin D, folic acid, calcium, iron, and omega-3 fatty acids the pregnant participants were getting from their diet. The researchers compared the participants’ diets to nutrition recommendations for pregnancy to determine the amount of nutrients the participants would need from a prenatal vitamin to make up what they were missing in their diet.

The researchers compared over 20,000 prenatal vitamins available in the US, focusing on the nutrients that are most important for maternal and infant health: vitamin A, vitamin D, folic acid, calcium, iron, and omega-3 fatty acids.

What happens next?

In addition to the use of prenatal dietary supplements, pregnant women can adjust their diet to include more of the nutrients they need for a healthy pregnancy. Going forward, more research is needed to identify foods that pregnant women could eat to get enough of these nutrients.

Where can I learn more?

Access the full journal article, titled “Selecting a dietary supplement with appropriate dosing for six key nutrients in pregnancy" in The American Journal of Clinical Nutrition.

Read more information about healthy eating during pregnancy on the American College of Obstetricians and Gynecologists website.

The content is the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Published April 2023

Access the associated article.

Download this summary

ECHO Study Suggests Most Prenatal Vitamins May Not Provide All of the Nutrients Pregnant Women Need

ECHO Study Links COVID-19 Stress, Slightly Earlier Births

<< Back to Research Summaries

ECHO Study Links COVID-19 Stress, Slightly Earlier Births

Authors: Kim McKee, Sarah Comstock, et al.

Who sponsored this study?

The Environmental influences on Child Health Outcomes (ECHO) Program, Office of The Director, National Institutes of Health supported this research.

Why was this study needed?

The effects of depression and stress during pregnancy and their relationship to poor birth outcomes, such as preterm birth, are well documented. This study evaluated how maternal stress during the pandemic may have contributed to newborn health outcomes.

What were the study results?

Babies born to ECHO participants who were pregnant during the pandemic had similar birth weights but were born slightly earlier compared to babies born to ECHO participants who were pregnant between 2016-2019, prior to the pandemic. The study also found levels of stress were similar for ECHO participants who were pregnant between March 2020 and May 2021 compared to those who were pregnant between 2016 and 2019. However, more participants who gave birth from March to September 2020 reported being distressed about changes to their prenatal care and delivery compared with those who delivered after September 2020.

Footnote: Results reported here are for a single study. Other or future studies may provide new information or different results. You should always consult with a qualified healthcare provider for diagnosis and for answers to your personal questions.

What was the study's impact?

While other studies have noted increased levels of depression and anxiety among pregnant individuals during the COVID-19 pandemic, these trends were not observed in pregnant ECHO participants. These results suggest that many pregnant women in the United States may have already been experiencing stress before the pandemic that didn’t significantly increase following the start of the pandemic.

Who was involved?

This study included a total of 2,983 ECHO participants from 30 U.S. states and territories who delivered a baby between January 1, 2016 and May 31, 2021.

What happened during the study?

In this study, researchers evaluated medical records and maternal reports on birth weight, gestational age at delivery, and birth weight percentiles adjusted for gestational age at delivery among participants. Researchers also used data from pregnant participants across all time periods that measured depression and perceived stress. Participants who were pregnant during the pandemic reported on stress during the pandemic using a questionnaire developed during the pandemic for use with ECHO participants.

What happens next?

The study ended in May 2021 while the pandemic continued to create stressful and confusing conditions for pregnant women and their families. Similar analyses with data from additional pandemic periods could shed light on how the pandemic continues to affect pregnancy and infant health outcomes.

Where can I learn more?

Access the full journal article, titled “Perinatal Outcomes during versus Prior to the COVID-19 Pandemic and the Role of Maternal Depression and Perceived Stress: A Report from the ECHO Program,” in The American Journal of Perinatology.

The content is the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Download this summary

ECHO Study Links COVID-19 Stress, Slightly Earlier Births

ECHO Study Suggests Exposure to PFAS During Pregnancy May Be Linked to Lower Birthweights

<< Back to Research Summaries

ECHO Study Suggests Exposure to PFAS During Pregnancy May Be Linked to Lower Birthweights

Authors: Amy Padula, Tracey Woodruff, et al.

Who sponsored this study?

This research was supported by the Environmental influences on Child Health Outcomes (ECHO) program, the Office of the Director, and the National Institutes of Health.

Footnote: The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

What were the study results?

PFAS were found in almost all participants in the study. Researchers also found that in this study, participants with higher levels of PFAS exposure were more likely to have babies born with lower birthweight. These results did not find that stress played a role in the relationship between PFAS exposure and birthweight.

Footnote: Results reported here are for a single study. Other or future studies may provide new information or different results. You should not make changes to your health without first consulting your healthcare professional.

What was this study's impact?

The results of this study suggest that PFAS exposure during pregnancy is associated with lower birthweight in infants. However, outside of research studies, pregnant women are not usually tested for PFAS and are often unaware of their potential harms despite PFAS exposure from the environment being common. Therefore, it is important to address efforts to reduce and prevent further exposure to PFAS. Researchers need to better understand where people are most likely to be exposed to these chemicals given the wide range of exposure sources, from PFAS contamination in water to PFAS used in certain consumer products.

Why was this study needed?

It is important to know what the effects of per- and polyfluoroalkyl substances (PFAS) exposures may be on child and maternal health. This study is the largest of its kind and includes participants from across the US to help inform future research related to potential effects of PFAS exposures.

Who was involved?

This study included eleven ECHO pregnancy cohorts with a total of 3,339 participants from several states.

What happened during the study?

The researchers measured the concentration of PFAS, chemicals used in a wide range of consumer products, in the blood of pregnant women. They also surveyed these women about their stress levels throughout pregnancy. These measurements occurred over the past 20 years. The researchers then compared the birthweight for babies resulting from these pregnancies and recorded any instances of preterm birth.

What happens next?

The next step for researchers is to examine potential sources of PFAS exposures, including exposures from drinking water and consumer products. Future studies within ECHO may also examine how body mass index and preexisting conditions, such as diabetes during pregnancy or high blood pressure, may interact with PFAS exposures and contribute to the effects of PFAS on infant birthweight. Future studies may also examine additional chemicals that could contribute to lower birthweight in infants.

Where can I learn more?

The US Environmental Protection Agency (EPA) created a Roadmap to protect people and communities from PFAS contamination.

Access the full journal article, titled “Birth Outcomes in Relation to Prenatal Exposure to Per- and Polyfluoroalkyl Substances and Stress in the Environmental influences on Child Health Outcomes (ECHO) Program” in Environmental Health Perspectives.

The content is the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Published March 15, 2023

Access the associated article.

Download this summary

ECHO Study Suggests Exposure to PFAS During Pregnancy May Be Linked to Lower Birthweights

The Influence of Opioid Use Disorder Medications During Pregnancy on the Severity of Neonatal Opioid Withdrawal Syndrome

<< Back to Research Summaries

The Influence of Mediators on the Relationship Between Antenatal Opioid Agonist Exposure and the Severity of Neonatal Opioid Withdrawal Syndrome

Author(s): Lori A. Devlin, Zhuopei Hu, Songthip Ounpraseuth, Alan E. Simon, Robert D. Annett, Abhik Das, Janell F. Fuller, Rosemary D. Higgins, Stephanie L. Merhar, P. Brian Smith, Margaret M. Crawford, Lesley E. Cottrell, Adam J. Czynski, Sarah Newman, David A. Paul, Pablo J. Sánchez, Erin O. Semmens, M. Cody Smith, Bonny L. Whalen, Jessica N. Snowden, Leslie W. Young

Why was this study conducted?

Opioid use disorder is a treatable disease that can be managed with medicine for opioid use disorder (MOUD). This type of treatment is recommended for pregnant individuals by healthcare professionals to improve pregnancy and newborn outcomes.

Babies who were exposed to opioids during pregnancy may develop signs of neonatal opioid withdrawal syndrome (NOWS), including tremors; excessive crying and irritability; and problems with sleeping and feeding. This study looked at how MOUD use during pregnancy influenced the severity of NOWS symptoms.

What was done?

Data were collected from the medical records’ of 1294 opioid-exposed infants born at or cared for in 30 U.S. hospitals between July 2016 and June 2017. There were 859 infants exposed to MOUD (methadone or buprenorphine) and 435 infants exposed to opioids other than MOUD. We looked to see if infants needed medication to treat NOWS and how long they stayed in the hospital.

What was found?

The results suggest that exposure to MOUD (buprenorphine or methadone) during pregnancy increased the severity of NOWS. Infants exposed to MOUD were two times more likely to need an opioid medication to treat withdrawal. They also remained in the hospital 1.7 days longer than infants not exposed to MOUD. Some factors that reduced the severity of NOWS in infants treated with MOUD were adequate prenatal care, exposure to a single type of opioid, and not being exposed to other mood-changing drugs simultaneously. These factors also decreased the likelihood that infant would need opioid medicine to treat their NOWS symptoms and shortened their hospital stay. Infants exposed to buprenorphine instead of methadone had a shorter length of hospital stay and needed less treatment with opioid medication.

What do the results mean?

Medical experts recommend that pregnant women with an opioid use disorder use MOUD for healthier pregnancies. MOUD can reduce the chances of pregnancy loss, premature birth, infection, and poor growth of the infant. However, using MOUD may be related to increases in the severity of NOWS. Learning more about how MOUD affects the severity of NOWS can help doctors improve the health of mothers using MOUD and their babies. These results also suggest that adequate prenatal care can help improve pregnancy and birth outcomes, and highlight the importance of identifying barriers to receiving sufficient prenatal care as an opportunity to improve infant outcomes.

Who sponsored the study?

This research was supported by the Environmental Influences on Child Health Outcomes Program, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, the National Center for Advancing Translational Sciences, and the National Institutes of Health.

Appreciation:

We deeply appreciate the doctors, nurses, and hospitals that participated in the study and helped identify and extract information from the required medical records. Their enthusiastic collaboration made this study possible.

You may learn more about this publication here: https://link.springer.com/article/10.1007/s10995-022-03521-3

The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Published: March 11, 2023

Download this summary

The Influence of Mediators on the Relationship Between Antenatal Opioid Agonist Exposure and the Severity of Neonatal Opioid Withdrawal Syndrome

Read Related Research Summaries

“Eat, Sleep, Console” approach shown to be more effective in caring for newborns with neonatal opioid withdrawal syndrome

Author(s): Leslie Young, Lori Devlin, Stephanie Merhar, et al.

How does prenatal opioid exposure affect child outcomes?

Author(s): Elisabeth Conradt, Sheila Crowell and Barry Lester

Understanding characteristics associated with opioid use during pregnancy

Authors: Ruby H.N. Nguyen, Monica McGrath, et al.

Phenobarbital and Clonidine as Secondary Medications for Neonatal Opioid Withdrawal Syndrome

Author(s): Stephanie Merhar, Songthip Ounpraseuth, Lori Devlin, et al.

Site-Level Variation in the Characteristics and Care of Infants with Neonatal Opioid Withdrawal

Author(s): Leslie Young, Zhuopei Hu, Robert Annett, et al.

The ACT NOW Clinical Practice Survey: Gaps in the Care of Infants With Neonatal Opioid Withdrawal Syndrome

Author(s): Jessica Snowden, Akshatha, Robert Annett, et al.

ECHO Researchers Demonstrate Reliability of Room-Temperature, Methanol-Preserved Placental Samples for Measuring Metabolism

<< Back to Research Summaries

ECHO Researchers Demonstrate Reliability of Room-Temperature, Methanol-Preserved Placental Samples for Measuring Metabolism

Authors: Jennifer Straughen, et al.

Who sponsored this study?

This research was supported by the Environmental influences on Child Health Outcomes (ECHO) program, Office of The Director, National Institutes of Health.

What were the study results?

The results show that metabolic data with similar quality can be obtained from placental tissue samples preserved in methanol at room temperature than from flash-frozen samples—though a greater number of metabolites were typically detected in the methanol-fixed samples and the methanol extract.

Footnote: Results reported here are for a single study. Other or future studies may provide new information or different results. You should not make changes to your health without first consulting your healthcare professional.

What was the study's impact?

The results of this study show that placental tissue preservation in methanol at room temperature may be a suitable alternative method for analysis of placental metabolism. This method is more feasible and cost-effective than flash freezing, especially in community-based hospitals. As such, this study may make it easier for researchers to study the function of placentas and their potential relation to health outcomes.

Why was the study needed?

The placenta is an organ that provides nourishment to a developing fetus before it is born. Understanding metabolism within the placenta—the production and breakdown of molecules that provides energy to the placenta—might help researchers learn more about its function during pregnancy. To date, methods to collect placental samples to measure metabolism are expensive and require specialized equipment. In this study, researchers compared data from placental samples collected at room temperature to samples collected by flash-freezing, the standard method.

Who was involved?

The researchers collected placental samples from mothers within 15 minutes after delivery of the placenta at Henry Ford Health in Detroit, Michigan. All samples were anonymous.

What happened during the study?

The researchers collected pea-sized pieces of placenta tissue using the flash-freezing method and the test method (fixed in a solution of methanol at room temperature) and compared the resulting metabolism data.

What happens next?

More work is needed to describe the placental metabolic data revealed during this study and compare it to data from previous studies. Researchers will also need to repeat this study with a larger number of placentas to confirm the findings.

Where can I learn more?

Access the full journal article titled “Comparison of methanol fixation versus cryopreservation of the placenta for metabolomics analysis” published in Scientific Reports.

The content is the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Published March 11, 2023

Access the associated article.

Download this summary

ECHO Researchers Demonstrate Reliability of Room-Temperature, Methanol-Preserved Placental Samples for Measuring Metabolism